Compare · ITGR vs OM
ITGR vs OM
Side-by-side comparison of Integer Holdings Corporation (ITGR) and Outset Medical Inc. (OM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ITGR and OM operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- ITGR is the larger of the two at $4.26B, about 52.7x OM ($80.9M).
- Over the past year, ITGR is up 15.4% and OM is down 69.5% - ITGR leads by 84.8 points.
- ITGR has been more active in the news (16 items in the past 4 weeks vs 8 for OM).
- ITGR has more recent analyst coverage (23 ratings vs 13 for OM).
- Company
- Integer Holdings Corporation
- Outset Medical Inc.
- Price
- $125.38+0.38%
- $4.30+2.87%
- Market cap
- $4.26B
- $80.9M
- 1M return
- +26.04%
- -1.38%
- 1Y return
- +15.36%
- -69.48%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 16
- 8
- Recent ratings
- 23
- 13
Integer Holdings Corporation
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Outset Medical Inc.
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo Hemodialysis System, which comprises of a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Latest ITGR
- SEC Form DEFA14A filed by Integer Holdings Corporation
- INTEGER HOLDINGS: Kaskela Law Announces Probe into Adequacy of $127.00 Per Share Buyout Price – Fair or Inadequately Low for the Company’s Shareholders?
- SEC Form 10-Q filed by Integer Holdings Corporation
- SEC Form DEFA14A filed by Integer Holdings Corporation
- Integer Holdings Corporation filed SEC Form 8-K: Financial Statements and Exhibits
- SEC Form DEFA14A filed by Integer Holdings Corporation
- SEC Form DEFA14A filed by Integer Holdings Corporation
- SEC Form DEFA14A filed by Integer Holdings Corporation
- SEC Form DEFA14A filed by Integer Holdings Corporation
- SEC Form DEFA14A filed by Integer Holdings Corporation
Latest OM
- Chair and CEO Trigg Leslie sold $15,088 worth of shares (3,437 units at $4.39), decreasing direct ownership by 2% to 194,597 units (SEC Form 4) (tax withholding)
- General Counsel Brottem John L. sold $11,554 worth of shares (2,632 units at $4.39), decreasing direct ownership by 3% to 87,475 units (SEC Form 4) to cover withholding tax
- Chief Financial Officer Gaeta Renee sold $19,944 worth of shares (4,543 units at $4.39), decreasing direct ownership by 2% to 180,840 units (SEC Form 4) (for withholding tax)
- SEC Form 144 filed by Outset Medical Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Outset Medical Inc.
- SEC Form SCHEDULE 13G filed by Outset Medical Inc.
- SEC Form 10-Q filed by Outset Medical Inc.
- Outset Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
- Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)